Bio Green Med Solution (BGMS) EBIT Growth (3y) (2013 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.88 Bn | 133.03 Bn | 2.84 Bn | 6.70% |
| 2 | Regeneron Pharmaceuticals | 86.94 Bn | 78.95 Bn | 3.93 Bn | 8.36% |
| 3 | Argenx Se | 64.96 Bn | 59.78 Bn | 1.37 Bn | 89.72% |
| 4 | Moderna | 57.34 Bn | 52.20 Bn | 52.00 Mn | 24.14% |
| 5 | Revolution Medicines | 44.63 Bn | 44.63 Bn | - | - |
| 6 | BeOne Medicines | 40.44 Bn | 35.34 Bn | 1.53 Bn | 44.54% |
| 7 | Alnylam Pharmaceuticals | 35.48 Bn | 32.17 Bn | 992.69 Mn | 44.34% |
| 8 | Royalty Pharma | 28.22 Bn | 27.38 Bn | - | -18.82% |
| 9 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 81.27% |
| 10 | Bio Green Med Solution | 5.03 Mn | 1.24 Mn | 79,000.00 | 58.69% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 58.69% |
| Mar 31, 2026 | 67.73% |
| Dec 31, 2025 | 50.36% |
| Sep 30, 2025 | 46.47% |
| Jun 30, 2025 | 40.01% |
| Mar 31, 2025 | 13.71% |
| Dec 31, 2024 | 33.72% |
| Sep 30, 2024 | 27.46% |
| Jun 30, 2024 | 15.78% |
| Mar 31, 2024 | -0.39% |
| Dec 31, 2023 | -19.16% |
| Sep 30, 2023 | -38.58% |
| Jun 30, 2023 | -33.86% |
| Mar 31, 2023 | -44.54% |
| Dec 31, 2022 | -46.83% |
| Sep 30, 2022 | -40.17% |
| Jun 30, 2022 | -35.27% |
| Mar 31, 2022 | -43.84% |
| Dec 31, 2021 | -36.57% |
| Sep 30, 2021 | -32.45% |